Related references
Note: Only part of the references are listed.Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology
Ryoichi Saito et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
Rachael M. Zemek et al.
NATURE PROTOCOLS (2020)
Solo: Doublet Identification in Single-Cell RNA-Seq via Semi-Supervised Deep Learning
Nicholas J. Bernstein et al.
CELL SYSTEMS (2020)
Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
Yan Qu et al.
CELL REPORTS (2020)
From Louvain to Leiden: guaranteeing well-connected communities
V. A. Traag et al.
SCIENTIFIC REPORTS (2019)
Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
Jingjing Duan et al.
CANCER MEDICINE (2018)
Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics
Marlon Stoeckius et al.
GENOME BIOLOGY (2018)
SCANPY: large-scale single-cell gene expression data analysis
F. Alexander Wolf et al.
GENOME BIOLOGY (2018)
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I. S. Mosely et al.
CANCER IMMUNOLOGY RESEARCH (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist
Rebecca Leyland et al.
CLINICAL CANCER RESEARCH (2017)
Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC
Jan Trost Jorgensen
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen et al.
CANCER DISCOVERY (2016)
Repeated fine-needle aspiration of solid tumours in mice allows the identification of multiple infiltrating immune cell types
Christina S. E. Carroll et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Immunotherapy and the concept of a clinical cure
Alexander M. M. Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2013)
A Bayesian Approach to Parallelism Testing in Bioassay
Steven J. Novick et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2012)
Minimally invasive assessment of tumor angiogenesis by fine needle aspiration and flow cytometry
Joseph L. Sottnik et al.
ANGIOGENESIS (2010)
A Fine-Needle Aspirate-Based Vulnerability Assay Identifies Polo-Like Kinase 1 as a Mediator of Gemcitabine Resistance in Pancreatic Cancer
Antonio Jimeno et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Share Paper
